Esperion to Participate in the 2022 Jefferies Global Healthcare Conference

Rhea-AI Summary

Esperion (NASDAQ: ESPR) announced that CEO Sheldon Koenig will present at the 2022 Jefferies Global Healthcare Conference on June 8, 2022, at 9:00 AM (ET). The presentation will include a webcast available on the company's website, with a replay accessible two hours after the event for 90 days. Esperion is focused on developing oral, once-daily non-statin medications aimed at lowering LDL-cholesterol, catering especially to patients with unmet needs. More details can be found on their website.

ANN ARBOR, Mich., June 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Sheldon Koenig, will present at the upcoming 2022 Jefferies Global Healthcare Conference on June 8^th, 2022.

Event:	2022 Jefferies Global Healthcare Conference
Date:	Wednesday, June 8th, 2022
Format:	Presentation and 1:1 Meetings
Time:	9:00 AM (ET)
Webcast:	Link

A live audio webcast can be accessed on the investor and media section of the Esperion website at https://www.esperion.com/investor-relations/events. Access to the webcast replay will be available approximately two hours after completion of the call and will be archived on the Company's website for approximately 90 days.

Esperion Therapeutics

Esperion works hard to make our medicines easy to get, easy to take and easy to have. We discover, develop and commercialize innovative medicines and combinations to lower cholesterol, especially for patients whose needs aren’t being met by the status quo. Our entrepreneurial team of industry leaders is inclusive, passionate and resourceful. We are singularly focused on managing cholesterol so you can improve your health easily. Esperion is the leader in the development of convenient oral, once-daily non-statin LDL-cholesterol lowering drugs for patients with high levels of bad cholesterol. For more information, please visit www.esperion.com and follow us on Twitter at www.twitter.com/EsperionInc.

Contact:
Corporate Communications
corporateteam@esperion.com

FAQ

When will Esperion present at the Jefferies Global Healthcare Conference?

Esperion will present on June 8, 2022, at 9:00 AM (ET).

How can I access the Esperion presentation webcast?

The webcast can be accessed on the investor section of the Esperion website at the provided link.

What is the focus of Esperion's presentation at the conference?

The presentation will likely focus on Esperion's innovative cholesterol-lowering medications.

How long will the replay of the Esperion conference presentation be available?

The replay will be available approximately two hours after the event and archived for roughly 90 days.

What is the significance of the Jefferies Global Healthcare Conference for ESPR?

It provides a platform for Esperion to showcase its initiatives and innovations in cholesterol management.